Back to search
Omitting Sentinel Lymph Node Biopsy in Early-stage Breast Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Omitting Sentinel Lymph Node Biopsy in Early-stage Breast Cancer trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Omitting Sentinel Lymph Node Biopsy in Early-stage Breast Cancer trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a multicenter, randomized, phase III non-inferiority trial in women aged 40 years or older with clinically node-negative (cN0), pathologically pT1 (≤2 c…
The goal of this clinical trial is to determine if the omission of sentinel lymph node biopsy is safe for early-stage breast cancer patients in our institution…